𝔖 Bobbio Scriptorium
✦   LIBER   ✦

EEG changes during long-term treatment with donepezil in Alzheimer's disease patients

✍ Scribed by E. A. Kogan; A. D. Korczyn; R. G. Virchovsky; S. Sh. Klimovizky; T. A. Treves; M. Y. Neufeld

Publisher
Springer
Year
2001
Tongue
English
Weight
52 KB
Volume
108
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Verbal repetition in patients with Alzhe
Verbal repetition in patients with Alzheimer's disease who receive donepezil
✍ Elissa Asp; France Cloutier; Sherri Fay; Cheryl Cook; Mary Lou Robertson; John F πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 96 KB

## Background: Current outcome measures for alzheimer's disease (ad) drugs have been criticized as insufficiently patient-centred. one commonly unmeasured goal of patients and caregivers is verbal repetition. ## Objectives: We examined how often reducing repetition (of questions, statements or st

Preliminary communication: Urodynamic as
Preliminary communication: Urodynamic assessment of donepezil hydrochloride in patients with Alzheimer's disease
✍ Ryuji Sakakibara; Tomoyuki Uchiyama; Mitsuharu Yoshiyama; Tomoyuki Yamanishi; Ta πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 113 KB

## Abstract ## Background and Aims Donepezil hydrochloride, a central cholinergic drug, is widely used for improving cognitive decline in Alzheimer's disease (AD). We investigated whether donepezil might affect the lower urinary tract (LUT) function in AD. ## Methods Alzheimer's Disease Assessme

Tolerability of switching from donepezil
Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease
✍ Gunhild Waldemar; Maritta HyvΓ€rinen; Mette Krog Josiassen; Alex KΓΈrner; Heikki L πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 44 KB πŸ‘ 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving